These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39294051)

  • 1. Comparing Three Ultrasound-Based Techniques for Diagnosing and Grading Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Wang P; Song D; Han J; Zhang J; Chen H; Gao R; Shen H; Li J
    Acad Radiol; 2024 Sep; ():. PubMed ID: 39294051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing ultrasound-derived fat fraction and MRI-PDFF for quantifying hepatic steatosis: a real-world prospective study.
    Qi R; Lu L; He T; Zhang L; Lin Y; Bao L
    Eur Radiol; 2024 Oct; ():. PubMed ID: 39414658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-Derived Fat Fraction for Hepatic Steatosis Assessment: Prospective Study of Agreement With MRI PDFF and Sources of Variability in a Heterogeneous Population.
    Kubale R; Schneider G; Lessenich CPN; Buecker A; Wassenberg S; Torres G; Gurung A; Hall T; Labyed Y
    AJR Am J Roentgenol; 2024 Jun; 222(6):e2330775. PubMed ID: 38506537
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-invasive assessment of hepatic steatosis by ultrasound-derived fat fraction in individuals at high-risk for metabolic dysfunction-associated steatotic liver disease.
    Tavaglione F; Flagiello V; Terracciani F; Gallo P; Capparelli E; Spiezia C; De Vincentis A; Palermo A; Scriccia S; Galati G; Napoli N; Daniels SJ; Blau JE; Carlsson B; Khazrai YM; Incalzi RA; Picardi A; Vespasiani-Gentilucci U
    Diabetes Metab Res Rev; 2024 Mar; 40(3):e3787. PubMed ID: 38461408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison With MRI Proton Density Fat Fraction as Reference Standard.
    Dillman JR; Thapaliya S; Tkach JA; Trout AT
    AJR Am J Roentgenol; 2022 Nov; 219(5):784-791. PubMed ID: 35674351
    [No Abstract]   [Full Text] [Related]  

  • 6. Ultrasound-derived fat fraction for detection of hepatic steatosis and quantification of liver fat content.
    De Robertis R; Spoto F; Autelitano D; Guagenti D; Olivieri A; Zanutto P; Incarbone G; D'Onofrio M
    Radiol Med; 2023 Oct; 128(10):1174-1180. PubMed ID: 37568072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of MRI proton density fat fraction in hepatic steatosis: a systematic review and meta-analysis.
    Azizi N; Naghibi H; Shakiba M; Morsali M; Zarei D; Abbastabar H; Ghanaati H
    Eur Radiol; 2024 Sep; ():. PubMed ID: 39254718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of ultrasound-derived fat fraction for the detection and quantification of hepatic steatosis in patients with liver biopsy.
    Nakamura Y; Hirooka M; Koizumi Y; Yano R; Imai Y; Watanabe T; Yoshida O; Tokumoto Y; Abe M; Hiasa Y
    J Med Ultrason (2001); 2024 Jun; ():. PubMed ID: 38918301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease.
    Shao CX; Ye J; Dong Z; Li F; Lin Y; Liao B; Feng S; Zhong B
    Ther Adv Chronic Dis; 2021; 12():20406223211033119. PubMed ID: 34408822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of controlled attenuation parameter for liver steatosis in patients at risk for metabolic dysfunction-associated steatotic liver disease using magnetic resonance imaging: a systematic review and meta-analysis.
    Malandris K; Katsoula A; Liakos A; Bekiari E; Karagiannis T; Theocharidou E; Giouleme O; Sinakos E; Tsapas A
    Ann Gastroenterol; 2024; 37(5):579-587. PubMed ID: 39238800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR Spectroscopy-derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis.
    Runge JH; Smits LP; Verheij J; Depla A; Kuiken SD; Baak BC; Nederveen AJ; Beuers U; Stoker J
    Radiology; 2018 Feb; 286(2):547-556. PubMed ID: 28915103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time ultrasound-derived fat fraction in pediatric population: feasibility validation with MR-PDFF.
    Zalcman M; Barth RA; Rubesova E
    Pediatr Radiol; 2023 Nov; 53(12):2466-2475. PubMed ID: 37667050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.
    Kuchay MS; Choudhary NS; Sharma D; Krishan S; Mishra SK; Wasir JS; Singh MK; Saraf N; Dhampalwar S; Sud R
    J Clin Exp Hepatol; 2022; 12(3):893-898. PubMed ID: 35677514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Method for Ultrasound-Derived Fat Fraction Using an Integrated Phantom.
    Labyed Y; Milkowski A
    J Ultrasound Med; 2020 Dec; 39(12):2427-2438. PubMed ID: 32525261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy.
    Jia S; Zhao Y; Liu J; Guo X; Chen M; Zhou S; Zhou J
    Front Pediatr; 2021; 9():784221. PubMed ID: 35087774
    [No Abstract]   [Full Text] [Related]  

  • 16. Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates.
    Garteiser P; Castera L; Coupaye M; Doblas S; Calabrese D; Dioguardi Burgio M; Ledoux S; Bedossa P; Esposito-Farèse M; Msika S; Van Beers BE; Jouët P
    JHEP Rep; 2021 Dec; 3(6):100381. PubMed ID: 34786549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hepatic steatosis promotes increased liver stiffness in the early stages of metabolic dysfunction-associated steatotic liver disease.
    Kumada T; Toyoda H; Ogawa S; Gotoh T; Suzuki Y; Sugimoto K; Yoshida Y; Kuroda H; Kamada Y; Sumida Y; Ito T; Akita T; Tanaka J
    Liver Int; 2024 Jul; 44(7):1700-1714. PubMed ID: 38558221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the efficacy of 8 non-invasive models in predicting MASLD and progression: a prospective study.
    Yang A; Zhu X; Zhang L; Zhang D; Jin M; Lv G; Ding Y
    BMC Gastroenterol; 2024 Oct; 24(1):365. PubMed ID: 39402469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease.
    Gu Q; Cen L; Lai J; Zhang Z; Pan J; Zhao F; Yu C; Li Y; Chen C; Chen W; Shen Z
    Eur J Clin Invest; 2021 Feb; 51(2):e13446. PubMed ID: 33128454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic steatosis using ultrasound-derived fat fraction: First technical and clinical evaluation.
    Huang YL; Cheng J; Wang Y; Xu XL; Wang SW; Wei L; Dong Y
    Clin Hemorheol Microcirc; 2024; 86(1-2):51-61. PubMed ID: 37638422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.